RadNet Reports Record Q3 2026 Revenue and Adjusts 2026 Guidance

RadNet, Inc. reported financial results for the third quarter of 2026, highlighting record quarterly revenue and adjusted EBITDA. The company reported total company revenue of $638.3 million for the third quarter of 2026, an increase of $115.4 million (22.1%) compared to the third quarter of 2025. Adjusted EBITDA for the same period was $105.0 million, representing a 23.8% increase year-over-year. The company’s adjusted diluted earnings per share were $0.30 for the third quarter of 2026, compared to $0.24 in the prior year.

RadNet’s Digital Health segment, which includes intersegment revenue, generated $32.9 million in revenue for the third quarter of 2026, a 32.6% increase from the prior year. However, Adjusted EBITDA for this segment decreased 11.8% to $3.0 million. The company noted that aggregate advanced imaging procedural volumes increased 19.9% in the third quarter of 2026, with MRI, CT, and PET/CT volumes rising by 18.3%, 22.0%, and 30.4%, respectively. On a same-center basis, advanced imaging volumes increased 8.9%.

As of September 30, 2026, RadNet held a cash balance of $750.6 million and maintained a Net Debt to Adjusted EBITDA ratio of 1.66x. The company also reported net loss for the third quarter of 2026 of $4.2 million, with a fully diluted net loss per share of $0.05, compared to net income of $5.4 million and earnings per share of $0.07 in the prior year.

RadNet has revised its 2026 guidance ranges for the Imaging Center segment, increasing the expected total net revenue to $2.385 billion to $2.435 billion. The company also raised its guidance for Adjusted EBITDA to $350 million to $363 million and Free Cash Flow to $120 million to $130 million. The Digital Health segment guidance was adjusted to include a range for non-capitalized R&D expenses of $17 million to $19 million. The company stated that the pending acquisition of ONRAD is expected to provide further growth opportunities.

RadNet’s management will host a conference call on Monday, November 9, 2026, at 10:30 a.m. Eastern Time to discuss these results.